New study: European drug prices average 40 percent less than U.S. prices for top-selling drugs
Thursday, July 9th, 2009
A new study by the pharmaceutical research firm Decision Resources has determined that European prices for 170 top-selling prescription medications averaged 40 percent less than U.S. prices in 2008, with even greater drug discounts is some countries.
Some of the best bargains, relative to U.S. prices, were on Prozac, Ambien and Tegretol, the study reported.
Neil Grubert, director of pricing research for Decision Resources, said such price discrepancies are not only a concern to U.S. consumers, but also to insurance providers and pharmacy benefit managers:
The current economic downturn will focus increasing attention on the cost of prescription drugs, and many payers will look to compare the prices they pay with prices in other markets. The United States is widely assumed to be by far the most expensive pharmaceutical market, but pharmaceutical companies and payers need to be aware of the enormous price variations by therapeutic area and drug type from one country to another.
Decision Resources’ 2009 Chartbook of International Pharmaceutical Prices examines overall price differentials among the world’s largest pharmaceutical markets, including the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Many Freebee Foreign Pharmacy members have discovered discounts greater than 40 percent — even up to 80 percent — using Freebee’s comparison shopping search engine.


